Invivyd Inc (IVVD)
2.44
-0.02
(-0.81%)
USD |
NASDAQ |
May 16, 16:00
2.33
-0.11
(-4.51%)
After-Hours: 20:00
Invivyd Price to Book Value: 1.631 for May 16, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 15, 2024 | 1.644 |
| May 14, 2024 | 1.624 |
| May 13, 2024 | 1.584 |
| May 10, 2024 | 1.511 |
| May 09, 2024 | 1.618 |
| May 08, 2024 | 1.691 |
| May 07, 2024 | 1.678 |
| May 06, 2024 | 1.578 |
| May 03, 2024 | 1.618 |
| May 02, 2024 | 1.584 |
| May 01, 2024 | 1.616 |
| April 30, 2024 | 1.483 |
| April 29, 2024 | 1.389 |
| April 26, 2024 | 1.436 |
| April 25, 2024 | 1.383 |
| April 24, 2024 | 1.423 |
| April 23, 2024 | 1.516 |
| April 22, 2024 | 1.463 |
| April 19, 2024 | 1.536 |
| April 18, 2024 | 1.570 |
| April 17, 2024 | 1.656 |
| April 16, 2024 | 1.803 |
| April 15, 2024 | 1.877 |
| April 12, 2024 | 1.970 |
| April 11, 2024 | 2.040 |
| Date | Value |
|---|---|
| April 10, 2024 | 2.010 |
| April 09, 2024 | 2.017 |
| April 08, 2024 | 2.044 |
| April 05, 2024 | 2.204 |
| April 04, 2024 | 2.391 |
| April 03, 2024 | 2.625 |
| April 02, 2024 | 2.545 |
| April 01, 2024 | 2.839 |
| March 28, 2024 | 2.983 |
| March 27, 2024 | 2.687 |
| March 26, 2024 | 2.459 |
| March 25, 2024 | 2.170 |
| March 22, 2024 | 2.929 |
| March 21, 2024 | 2.076 |
| March 20, 2024 | 2.136 |
| March 19, 2024 | 2.224 |
| March 18, 2024 | 2.230 |
| March 15, 2024 | 2.418 |
| March 14, 2024 | 2.452 |
| March 13, 2024 | 2.479 |
| March 12, 2024 | 2.432 |
| March 11, 2024 | 2.491 |
| March 08, 2024 | 2.471 |
| March 07, 2024 | 2.552 |
| March 06, 2024 | 2.558 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3518
Minimum
Jun 26 2023
8.265
Maximum
Nov 30 2021
1.387
Average
0.8385
Median
Jun 07 2022
Price to Book Value Benchmarks
| Vanda Pharmaceuticals Inc | 0.5975 |
| Viking Therapeutics Inc | 8.166 |
| Stoke Therapeutics Inc | 5.210 |
| 180 Life Sciences Corp | -- |
| MAIA Biotechnology Inc | 133.62 |
Price to Book Value Related Metrics
| Price | 2.44 |
| Earnings Yield | -76.64% |
| Market Cap | 291.13M |